Inventor · disambiguated record
Jennifer Maynard
Also filed as: MAYNARD JENNIFER · MAYNARD JENNIFER A
9 granted patents·10 pending applications·25 citations·filing 2002–2022
84Inventor score
Top patents by PatentIndex Score
19 records- 0187US9512204B2Humanized pertussis antibodies and uses thereofUNIV TEXAS·Filed 2015·Granted Dec 6, 2016·7 cites·5 claims
- 0281US8653243B2Pertussis antibodies and uses thereofMAYNARD JENNIFER·Filed 2011·Granted Feb 18, 2014·6 cites·3 claims
- 0378US10035846B2Humanized pertussis antibodies and uses thereofUNIV TEXAS·Filed 2016·Granted Jul 31, 2018·2 cites·4 claims
- 0474US7446182B1Recombinant antibodies for the detection and neutralization of anthrax toxinUNIV TEXAS·Filed 2002·Granted Nov 4, 2008·7 cites·16 claims
- 0572US9260510B2Pertussis antibodies and uses thereofUNIV TEXAS·Filed 2013·Granted Feb 16, 2016·1 cites·11 claims
- 0668US12422441B2Antibodies that bind to natively folded myocilinGEORGIA TECH RES INST·Filed 2019·Granted Sep 23, 2025·1 cites·18 claims
- 0768US10450352B2Engineered polypeptides for antigen deliveryUNIV TEXAS·Filed 2017·Granted Oct 22, 2019·1 cites·20 claims
- 0861US10526400B2Humanized pertussis antibodies and used thereofUNIV TEXAS·Filed 2018·Granted Jan 7, 2020·0 cites·4 claims
- 0960US2025188186A1Ph-selective antibody fc domainsUNIV TEXAS·Filed 2022·Application pending·0 cites
- 1058US2024294611A1Cross-reactive antibodies recognizing the coronavirus spike s2 domainPADLAN EDUARDO·Filed 2022·Application pending·0 cites
- 1156US2025127885A1Engineered fc domains and engineered hcmv viral fc receptorsUNIV TEXAS·Filed 2022·Application pending·0 cites
- 1252US2023242594A1Engineered coronavirus spike (s) protein and methods of use thereofUNIV TEXAS·Filed 2021·Application pending·0 cites
- 1351US2016304588A1Pertussis antibodies and uses thereofUNIV TEXAS·Filed 2016·Application pending·0 cites
- 1445US2021332112A1Stabilized pertussis antibodies with extended half-lifeUNIV TEXAS·Filed 2017·Application pending·0 cites
- 1544US2022144916A1High affinity engineered t-cell receptors targeting cmv infected cellsUNIV TEXAS·Filed 2020·Application pending·0 cites
- 1644US2023227541A1Anti-myocilin olf antibodies and methods of use thereofGEORGIA TECH RES INST·Filed 2021·Application pending·0 cites
- 1742US2012230913A1Protein nanoparticle dispersionsJOHNSTON KEITH P·Filed 2012·Application pending·0 cites
- 1840US10538579B2Bispecific pertussis antibodiesUNIV TEXAS·Filed 2017·Granted Jan 21, 2020·0 cites·10 claims
- 1931US2018256699A1Bordetella adenylate cyclase toxin vaccines and neutralizing antibodiesUNIV TEXAS·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →